243 related articles for article (PubMed ID: 17524652)
1. QSAR study of selective ligands for the thyroid hormone receptor beta.
Liu H; Gramatica P
Bioorg Med Chem; 2007 Aug; 15(15):5251-61. PubMed ID: 17524652
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
Wang XS; Tang H; Golbraikh A; Tropsha A
J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
[TBL] [Abstract][Full Text] [Related]
3. QSAR study of imidazoline antihypertensive drugs.
Nikolic K; Filipic S; Agbaba D
Bioorg Med Chem; 2008 Aug; 16(15):7134-40. PubMed ID: 18621536
[TBL] [Abstract][Full Text] [Related]
4. Prediction of binding affinities to beta1 isoform of human thyroid hormone receptor by genetic algorithm and projection pursuit regression.
Ren Y; Liu H; Li S; Yao X; Liu M
Bioorg Med Chem Lett; 2007 May; 17(9):2474-82. PubMed ID: 17337187
[TBL] [Abstract][Full Text] [Related]
5. Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor.
Xia B; Ma W; Zheng B; Zhang X; Fan B
Eur J Med Chem; 2008 Jul; 43(7):1489-98. PubMed ID: 17964693
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
[TBL] [Abstract][Full Text] [Related]
7. QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles.
Liu H; Papa E; Gramatica P
Chem Res Toxicol; 2006 Nov; 19(11):1540-8. PubMed ID: 17112243
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR and molecular docking studies of selective agonists for the thyroid hormone receptor beta.
Du J; Qin J; Liu H; Yao X
J Mol Graph Model; 2008 Sep; 27(2):95-104. PubMed ID: 18436460
[TBL] [Abstract][Full Text] [Related]
9. QSAR study of selective I1-imidazoline receptor ligands.
Nikolic K; Filipic S; Agbaba D
SAR QSAR Environ Res; 2009; 20(1-2):133-44. PubMed ID: 19343588
[TBL] [Abstract][Full Text] [Related]
10. G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validation.
Rolland C; Gozalbes R; Nicolaï E; Paugam MF; Coussy L; Barbosa F; Horvath D; Revah F
J Med Chem; 2005 Oct; 48(21):6563-74. PubMed ID: 16220973
[TBL] [Abstract][Full Text] [Related]
11. Structure-based quantitative structure--activity relationship modeling of estrogen receptor β-ligands.
Dong X; Hilliard SG; Zheng W
Future Med Chem; 2011 Jun; 3(8):933-45. PubMed ID: 21707397
[TBL] [Abstract][Full Text] [Related]
12. Simulating alpha/beta selectivity at the human thyroid hormone receptor: consensus scoring using multidimensional QSAR.
Vedani A; Zumstein M; Lill MA; Ernst B
ChemMedChem; 2007 Jan; 2(1):78-87. PubMed ID: 17096449
[TBL] [Abstract][Full Text] [Related]
13. Statistically validated QSARs, based on theoretical descriptors, for modeling aquatic toxicity of organic chemicals in Pimephales promelas (fathead minnow).
Papa E; Villa F; Gramatica P
J Chem Inf Model; 2005; 45(5):1256-66. PubMed ID: 16180902
[TBL] [Abstract][Full Text] [Related]
14. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
[TBL] [Abstract][Full Text] [Related]
15. Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Pérez-Garrido A; Morales Helguera A; Abellán Guillén A; Cordeiro MN; Garrido Escudero A
Bioorg Med Chem; 2009 Jan; 17(2):896-904. PubMed ID: 19056282
[TBL] [Abstract][Full Text] [Related]
16. 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors.
Falchi F; Manetti F; Carraro F; Naldini A; Maga G; Crespan E; Schenone S; Bruno O; Brullo C; Botta M
ChemMedChem; 2009 Jun; 4(6):976-87. PubMed ID: 19326384
[TBL] [Abstract][Full Text] [Related]
17. Novel ligands for the chemokine receptor-3 (CCR3): a receptor-modeling study based on 5D-QSAR.
Vedani A; Dobler M; Dollinger H; Hasselbach KM; Birke F; Lill MA
J Med Chem; 2005 Mar; 48(5):1515-27. PubMed ID: 15743194
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis.
Zhu H; Tropsha A; Fourches D; Varnek A; Papa E; Gramatica P; Oberg T; Dao P; Cherkasov A; Tetko IV
J Chem Inf Model; 2008 Apr; 48(4):766-84. PubMed ID: 18311912
[TBL] [Abstract][Full Text] [Related]
19. QSAR modeling of the interaction of flavonoids with GABA(A) receptor.
Duchowicz PR; Vitale MG; Castro EA; Autino JC; Romanelli GP; Bennardi DO
Eur J Med Chem; 2008 Aug; 43(8):1593-602. PubMed ID: 18158201
[TBL] [Abstract][Full Text] [Related]
20. Simultaneously optimized support vector regression combined with genetic algorithm for QSAR analysis of KDR/VEGFR-2 inhibitors.
Sun M; Chen J; Cai J; Cao M; Yin S; Ji M
Chem Biol Drug Des; 2010 May; 75(5):494-505. PubMed ID: 20486936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
